Japan society of clinical oncology clinical practice guidelines 2024 for fertility preservation in childhood, adolescent, and young adult cancer patients: part 2

BACKGROUND: The Japan Society of Clinical Oncology (JSCO) Clinical Practice Guidelines 2024 for Fertility Preservation in Childhood, Adolescent, and Young Adult (CAYA) Cancer Patients and Related Diseases provide updated guidance for oncofertility care in Japan. This article, Part 2 of the guideline series, addresses gynecologic, breast, and urologic cancers; childhood cancer and related diseases; and hematologic malignancies. METHODS: Background Questions (BQs), Clinical Questions (CQs), and Future Questions (FQs) were developed for each disease area. CQs were addressed through systematic reviews and resulted in evidence-based recommendations, whereas BQs summarized established clinical knowledge and FQs addressed important issues for which evidence-based recommendations could not be formulated. Recommendations were developed through systematic review and consensus processes using the Evidence-to-Decision framework, with consideration of the certainty of evidence, benefits and harms, patient values, acceptability, and feasibility. RESULTS: Disease-specific recommendations, statements, and explanatory texts are presented for fertility preservation and reproductive support in the five clinical areas. Because evidence remains limited for several clinical issues, decisions should be individualized according to the patient's age, disease status, planned treatment, urgency of treatment initiation, and reproductive wishes. CONCLUSIONS: These guidelines emphasize prioritization of cancer treatment, timely individualized counseling, and multidisciplinary collaboration among oncologists, reproductive medicine specialists, pediatricians, nurses, and other healthcare professionals. Such collaboration is essential to support informed decision-making and optimize oncofertility care for CAYA patients.

Authors

Institutions

Publication Details

Journal
International Journal of Clinical Oncology
Published
2026-11-18
DOI
https://doi.org/10.1007/s10147-026-03235-4
Primary Topic
Reproductive Biology and Fertility
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Japan society of clinical oncology clinical practice guidelines 2024 for fertility preservation in childhood, adolescent, and young adult cancer patients: part 2

Miyuki Harada, Tomoyuki Aruga, Wataru Yamagami, Akihiro Iguchi et al.
2 links
International Journal of Clinical Oncology
Reproductive Biology and Fertility
article

Japan society of clinical oncology clinical practice guidelines 2024 for fertility preservation in childhood, adolescent, and young adult cancer patients: part 2

Miyuki Harada, Tomoyuki Aruga, Wataru Yamagami, Akihiro Iguchi, Hiromitsu Negoro, Gentaro Izumi, Tomonori Ishikawa, Yutaka Osuga, Nao Suzuki, Tadashi Maezawa, Hideyuki Iwahata, Satoshi Yanagida, Yodo Sugishita, Yasushi Yumura, Mitsutoshi Yamada, Shinichi Yamashita, Toshiyuki Iwahata, Teppei Takeshima, Arisa Ueki, Yuko Sanada, Fuminori Kimura, Atsuko Kitano, Tsuguo Iwatani, Takahiro Osawa, Shinsuke Kataoka, Motohiro Matsui, Satoshi Tamauchi, Nozomi Takahashi, Chikako Kiyotani, Michio Kitajima, Taisuke Mori, Tatsuro Furui, Hiroyuki Takahashi, Yuma Tada, Masahiro Ashizawa, Ryoko Ichikawa, Takashi Kawahara
article en

Abstract

BACKGROUND: The Japan Society of Clinical Oncology (JSCO) Clinical Practice Guidelines 2024 for Fertility Preservation in Childhood, Adolescent, and Young Adult (CAYA) Cancer Patients and Related Diseases provide updated guidance for oncofertility care in Japan. This article, Part 2 of the guideline series, addresses gynecologic, breast, and urologic cancers; childhood cancer and related diseases; and hematologic malignancies. METHODS: Background Questions (BQs), Clinical Questions (CQs), and Future Questions (FQs) were developed for each disease area. CQs were addressed through systematic reviews and resulted in evidence-based recommendations, whereas BQs summarized established clinical knowledge and FQs addressed important issues for which evidence-based recommendations could not be formulated. Recommendations were developed through systematic review and consensus processes using the Evidence-to-Decision framework, with consideration of the certainty of evidence, benefits and harms, patient values, acceptability, and feasibility. RESULTS: Disease-specific recommendations, statements, and explanatory texts are presented for fertility preservation and reproductive support in the five clinical areas. Because evidence remains limited for several clinical issues, decisions should be individualized according to the patient's age, disease status, planned treatment, urgency of treatment initiation, and reproductive wishes. CONCLUSIONS: These guidelines emphasize prioritization of cancer treatment, timely individualized counseling, and multidisciplinary collaboration among oncologists, reproductive medicine specialists, pediatricians, nurses, and other healthcare professionals. Such collaboration is essential to support informed decision-making and optimize oncofertility care for CAYA patients.

International Journal of Clinical Oncology
Dokkyo University (JP), Jikei University School of Medicine (JP), Fujita Health University (JP), University of Tsukuba (JP), Jichi Medical University (JP), St. Marianna University School of Medicine (JP), Tohoku University (JP), Keio University (JP), Yokohama City University Medical Center (JP), Fukuoka International University (JP), Gifu University of Medical Science (JP), Kyoto Prefectural University of Medicine (JP), St. Luke's International Hospital (JP), Nagoya University Hospital (JP), National Center For Child Health and Development (JP), Saitama International Medical Center (JP), The Cancer Institute Hospital (JP), Dokkyo Medical University Saitama Medical Center (JP), Tokyo Metropolitan Children's Medical Center (JP), Osaka International Cancer Institute (JP), Jichi Medical University Hospital (JP), Tokyo Medical and Dental University Hospital (JP), Japanese Foundation For Cancer Research (JP), Kanagawa Cancer Center (JP), Institute of Science Tokyo (JP), Fukuoka International University of Health and Welfare (JP), Takagi Hospital (JP), Nara Medical University (JP), Niigata University (JP), The University of Tokyo (JP), Dokkyo Medical University (JP), International University of Health and Welfare (JP), Saitama Medical University (JP), Yokohama City University (JP)
Ministry of Health, Labour and Welfare, University of Tokyo
Good health and well-being
Reproductive Biology and Fertility
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon